AMAG Pharmaceuticals Inc (NASDAQ:AMAG)
| 20.65 Data as of Jun 19 |  -0.08 / -0.39%Today’s Change | 13.85 Today|||52-Week Range 25.67 | +40.38% Year-to-Date |
Latest AMAG News | Press Releases
Today’s Trading
| Previous close | 20.73 |
| Today’s open | 20.80 |
| Day’s range | -- - -- |
| Volume | 129,662 |
| Average volume (3 months) | 139,439 |
| Market cap | $447.2M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | +78.57% |
| Earnings growth (this year) | +19.78% |
| Earnings growth (next 5 years) | +35.00% |
| Revenue growth (last year) | +39.39% |
| P/E ratio | NM |
| Price/Sales | 3.69 |
| Price/Book | 2.58 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALRPRBAlere Inc | -2.45 | -1.05% |
| TRIBTrinity Biotech PLC | -0.12 | -0.70% |
| DNDNDendreon Corp | -0.09 | -2.21% |
| BDSIBioDelivery Sciences... | -0.13 | -2.79% |
Data as of 4:00pm ET, 06/19/2013
Financials
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $85.4M |
| Annual profit (last year) | -$16.8M |
| Net profit margin | -19.62% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director William K. Heiden, MBA |
Chief Operating Officer & Executive Vice President Frank E. Thomas, CPA |
Corporate headquarters Lexington, Massachusetts |
Forecasts
